VEGF-dependent testicular vascularisation involves MEK1/2 signalling and the essential angiogenesis factors, SOX7 and SOX17
Details
Publication Year 2024-10-01,Volume 22,Issue #1,Page 222
Journal Title
BMC Biology
Abstract
BACKGROUND: Abnormalities of in utero testis development are strongly associated with reproductive health conditions, including male infertility and testis cancer. In mouse testes, SOX9 and FGF9 support Sertoli cell development, while VEGF signalling is essential for the establishment of vasculature. The mitogen-activated protein kinase (MAPK) pathway is a major signalling cascade, essential for cell proliferation, differentiation and activation of Sry during primary sex-determination, but little is known about its function during fetal testis morphogenesis. We explored potential functions of MAPK signalling immediately after the establishment of testis cords in embryonic day (E)12.5 Oct4-eGFP transgenic mouse testes cultured using a MEK1/2 inhibitor. RESULTS: RNA sequencing in isolated gonadal somatic cells identified 116 and 114 differentially expressed genes after 24 and 72 h of MEK1/2 inhibition, respectively. Ingenuity Pathway Analysis revealed an association of MEK1/2 signalling with biological functions such as angiogenesis, vasculogenesis and cell migration. This included a failure to upregulate the master transcriptional regulators of vascular development, Sox7 and Sox17, VEGF receptor genes, the cell adhesion factor gene Cd31 and a range of other endothelial cell markers such as Cdh5 (encoding VE-cadherin) and gap junction genes Gja4 and Gja5. In contrast, only a small number of Sertoli cell enriched genes were affected. Immunofluorescent analyses of control testes revealed that the MEK1/2 downstream target, ERK1/2 was phosphorylated in endothelial cells and Sertoli cells. Inhibition of MEK1/2 eliminated pERK1/2 in fetal testes, and CD31, VE-cadherin, SOX7 and SOX17 and endothelial cells were lost. Consistent with a role for VEGF in driving endothelial cell development in the testis, inhibition of VEGFR also abrogated pERK1/2 and SOX7 and SOX17 expressing endothelial cells. Moreover, while Sertoli cell proliferation and localisation to the testis cord basement membrane was disrupted by inhibition of MEK1/2, it was unaffected by VEGFR inhibition. Instead, inhibition of FGF signalling compromised Sertoli cell proliferation and localisation to the testis cord basement membrane. CONCLUSIONS: Together, our data highlight an essential role for VEGF-dependent MEK1/2 signalling in promoting vasculature and indicate that FGF signalling through MEK1/2 regulates Sertoli cell organisation in the developing mouse testis.
Publisher
BMC
Keywords
Animals; Male; *SOXF Transcription Factors/metabolism/genetics; Mice; *Testis/metabolism/embryology/blood supply; *Mice, Transgenic; MAP Kinase Kinase 1/metabolism/genetics; MAP Kinase Kinase 2/metabolism/genetics; Vascular Endothelial Growth Factor A/metabolism/genetics; Signal Transduction; MAP Kinase Signaling System; Neovascularization, Physiologic; MAP Kinase Kinase Kinase 1/metabolism/genetics; Angiogenesis; HMGB Proteins; Endothelial cells; Fgf; MAP kinase; Mek1/2; Sox17; Sox7; Sertoli cells; Testis development; Vegf; Vasculature
Research Division(s)
Epigenetics And Development
PubMed ID
39354506
Open Access at Publisher's Site
https://doi.org/10.1186/s12915-024-02003-y
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-10-04 10:44:47
Last Modified: 2024-10-04 10:55:32
An error has occurred. This application may no longer respond until reloaded. Reload 🗙